Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zastaprazan by Onconic Therapeutics for Corrosive Esophagitis (Erosive Esophagitis): Likelihood of Approval
Zastaprazan is under clinical development by Onconic Therapeutics and currently in Phase III for Corrosive Esophagitis (Erosive Esophagitis). According to...
Zastaprazan by Onconic Therapeutics for Gastric Ulcers: Likelihood of Approval
Zastaprazan is under clinical development by Onconic Therapeutics and currently in Phase III for Gastric Ulcers. According to GlobalData, Phase...
Zastaprazan by Onconic Therapeutics for Gastric Ulcers: Likelihood of Approval
Zastaprazan is under clinical development by Onconic Therapeutics and currently in Phase III for Gastric Ulcers. According to GlobalData, Phase...